PMID- 29133562
OWN - NLM
STAT- In-Data-Review
LR  - 20180725
IS  - 1098-6596 (Electronic)
IS  - 0066-4804 (Linking)
VI  - 62
IP  - 2
DP  - 2018 Feb
TI  - Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in
      HIV-Positive Patients Ingesting Dabigatran.
LID - e02275-17 [pii]
LID - 10.1128/AAC.02275-17 [doi]
FAU - Kakadiya, Payal P
AU  - Kakadiya PP
AD  - Department of Pharmacy Services, Virginia Commonwealth University Health,
      Richmond, Virginia, USA.
FAU - Higginson, Robert T
AU  - Higginson RT
AD  - Department of Internal Medicine, Division of Infectious Diseases, Virginia
      Commonwealth University Health, Richmond, Virginia, USA.
FAU - Fulco, Patricia Pecora
AU  - Fulco PP
AD  - Department of Pharmacy Services, Virginia Commonwealth University Health,
      Richmond, Virginia, USA patricia.fulco@vcuhealth.org.
AD  - Department of Internal Medicine, Division of Infectious Diseases, Virginia
      Commonwealth University Health, Richmond, Virginia, USA.
LA  - eng
PT  - Letter
DEP - 20180125
PL  - United States
TA  - Antimicrob Agents Chemother
JT  - Antimicrobial agents and chemotherapy
JID - 0315061
PMC - PMC5786782
OTO - NOTNLM
OT  - antiretrovirals
OT  - cobicistat
OT  - dabigatran
OT  - human immunodeficiency virus
OT  - ritonavir
EDAT- 2017/11/15 06:00
MHDA- 2017/11/15 06:00
CRDT- 2017/11/15 06:00
PHST- 2017/11/15 06:00 [pubmed]
PHST- 2017/11/15 06:00 [medline]
PHST- 2017/11/15 06:00 [entrez]
AID - AAC.02275-17 [pii]
AID - 10.1128/AAC.02275-17 [doi]
PST - epublish
SO  - Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: AAC.02275-17. doi:
      10.1128/AAC.02275-17. Print 2018 Feb.